- Home
- SEATW vs BHST Comparison
SEATW vs BHST Comparison
Compare SEATW & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEATW
- BHST
- Stock Information
- Founded
- SEATW N/A
- BHST 2007
- Country
- SEATW United States
- BHST Canada
- Employees
- SEATW 768
- BHST N/A
- Industry
- SEATW Industrial Machinery/Components
- BHST
- Sector
- SEATW Industrials
- BHST
- Exchange
- SEATW Nasdaq
- BHST Nasdaq
- Market Cap
- SEATW N/A
- BHST N/A
- IPO Year
- SEATW N/A
- BHST N/A
- Fundamental
- Price
- SEATW $0.43
- BHST $5.83
- Analyst Decision
- SEATW
- BHST Strong Buy
- Analyst Count
- SEATW 0
- BHST 2
- Target Price
- SEATW N/A
- BHST $13.00
- AVG Volume (30 Days)
- SEATW N/A
- BHST 5.4K
- Earning Date
- SEATW N/A
- BHST 02-15-2025
- Dividend Yield
- SEATW N/A
- BHST N/A
- EPS Growth
- SEATW N/A
- BHST N/A
- EPS
- SEATW N/A
- BHST N/A
- Revenue
- SEATW N/A
- BHST $22,430,000.00
- Revenue This Year
- SEATW N/A
- BHST $140.81
- Revenue Next Year
- SEATW N/A
- BHST $120.86
- P/E Ratio
- SEATW N/A
- BHST N/A
- Revenue Growth
- SEATW N/A
- BHST 111.68
- 52 Week Low
- SEATW N/A
- BHST $0.00
- 52 Week High
- SEATW N/A
- BHST $7.38
- Technical
- Relative Strength Index (RSI)
- SEATW 65.83
- BHST N/A
- Support Level
- SEATW $0.16
- BHST N/A
- Resistance Level
- SEATW $0.38
- BHST N/A
- Average True Range (ATR)
- SEATW 0.07
- BHST 0.00
- MACD
- SEATW 0.01
- BHST 0.00
- Stochastic Oscillator
- SEATW 96.39
- BHST 0.00
About SEATW Vivid Seats Inc. Warrant
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale.
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.